Netta Jagpal
2024
In 2024, Netta Jagpal earned a total compensation of $120.5K as Chief Financial Officer at InMed Pharmaceuticals.
Compensation breakdown
| Bonus | $19,100 |
|---|---|
| Option Awards | $13,800 |
| Salary | $87,600 |
| Total | $120,500 |
Jagpal received $87.6K in salary, accounting for 73% of the total pay in 2024.
Jagpal also received $19.1K in bonus and $13.8K in option awards.
Rankings
In 2024, Netta Jagpal's compensation ranked 234th out of 244 executives tracked by ExecPay. In other words, Jagpal earned more than 4.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 234 out of 244 | 4th |
Division Manufacturing | 104 out of 108 | 4th |
Major group Chemicals And Allied Products | 43 out of 44 | 2nd |
Industry group Drugs | 40 out of 41 | 2nd |
Industry Pharmaceutical Preparations | 34 out of 35 | 3rd |
Source: SEC filing on October 28, 2024.
Jagpal's colleagues
We found five more compensation records of executives who worked with Netta Jagpal at InMed Pharmaceuticals in 2024.
2024
Eric Adams
InMed Pharmaceuticals
Chief Executive Officer
2024
Michael Woudenberg
InMed Pharmaceuticals
Chief Operating Officer
2024
Eric Hsu
InMed Pharmaceuticals
Senior Vice President, Preclinical Research & Development
2024
Alexandra Mancini
InMed Pharmaceuticals
Senior Vice President, Clinical & Regulatory Affairs
2024
Jonathan Tegge
InMed Pharmaceuticals